Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 729

Results For "ED"

7626 News Found

KK Pant is the new NPPA chairman
News | August 12, 2021

KK Pant is the new NPPA chairman

It plays a pivotal role in monitoring pharmaceutical pricing


Biocon Biologics and Viatris receive approval for first interchangeable biosimilar Semglee
Drug Approval | August 12, 2021

Biocon Biologics and Viatris receive approval for first interchangeable biosimilar Semglee

The company is eligible for 12 months exclusivity from launch


Natco Pharma PAT at Rs 75 crore for Q1FY22
News | August 12, 2021

Natco Pharma PAT at Rs 75 crore for Q1FY22

The company has strong product launches both in India and overseas


Global Healthcare Supply Chain Management market to reach US $ 3.6 billion by 2026
Supply Chain | August 11, 2021

Global Healthcare Supply Chain Management market to reach US $ 3.6 billion by 2026

A new market study published by Global Industry Analysts (GIA), released its report titled, ``Healthcare Supply Chain Management—Global Market Trajectory & Analytics.’’ We present excerpts from the report


Penpulimab Monoclonal Antibody (PD-1) Obtains Marketing Approval in China
Biotech | August 11, 2021

Penpulimab Monoclonal Antibody (PD-1) Obtains Marketing Approval in China

The approval is based on a multi-centre, single-arm, open-label pivotal clinical trial


GSK files application for MMR vaccine in the US
News | August 11, 2021

GSK files application for MMR vaccine in the US

If approved it will bring a second source of MMR vaccine to the US market


GW Pharmaceuticals receives approval for Epidyolex to treat seizures
Drug Approval | August 11, 2021

GW Pharmaceuticals receives approval for Epidyolex to treat seizures

TSC causes epilepsy in up to 85 % of patients, and up to 60 % of those patients do not respond to standard anti-seizure medicines


Cadila Healthcare net profit at Rs 587.2 cr in Q1FY22
News | August 11, 2021

Cadila Healthcare net profit at Rs 587.2 cr in Q1FY22

The company has also applied to DCGI for Emergency Use Authorization (EUA) for ZyCoVD, the world's first Plasmid DNA Vaccine


Marksons Pharma PAT at Rs 62.6 cr. for Q1FY22
News | August 11, 2021

Marksons Pharma PAT at Rs 62.6 cr. for Q1FY22

The company has tied up with OrbiMed as a financial partner for global reach


Lupin posts net profit of Rs 542.46 cr. in Q1FY22
News | August 11, 2021

Lupin posts net profit of Rs 542.46 cr. in Q1FY22

The profits were bolstered by the Boehringer Ingelheim MEK program income